Results
1 -
1 of
1
(Click
here to explore results)
- The cisplatin-based Pt(iv)-diclorofibrato multi-action anticancer prodrug exhibits excellent performances also under hypoxic conditions. Elisabetta Gabano, Mauro Ravera, Francesca Trivero, Stefano Tinello, Andrea Gallina, Ilaria Zanellato, Marzia B. Gariboldi, Elena Monti, Domenico Osella
, Dalton Trans.
, 2018
, 47
, 8268